Preferred Label : ertugliflozin;

MeSH note : a sodium-dependent glucose cotransporter 2 antagonist; structure in first source;

CISMeF synonym : PF 04971729;

MeSH synonym : 5-(4-chloro-3-(4-ethoxybenzyl)phenyl)-1-hydroxymethyl-6,8-dioxabicyclo(3.2.1)octane-2,3,4-triol;

MeSH hyponym : PF04971729; PF-04971729;

Is substance : O;

UNII : 6C282481IP;

Details


Main resources

You can consult :


https://www.has-sante.fr/jcms/p_3197837/fr/segluromet
2020
false
false
false
France
French
evaluation of the transparency committee
metformin and ertugliflozin
drug combinations
administration, oral
insurance, health, reimbursement
treatment outcome
hypoglycemic agents
adult
diabetes mellitus, type 2
metformin
ertugliflozin
hypoglycemic agents
Sodium-Glucose Transporter 2 Inhibitors
Sodium-Glucose Transporter 2 Inhibitors
ertugliflozin
metformin
Bridged Bicyclo Compounds, Heterocyclic
Bridged Bicyclo Compounds, Heterocyclic

---
https://www.has-sante.fr/portail/jcms/c_2913813/fr/steglujan
https://www.has-sante.fr/portail/jcms/c_2913813/fr/steglujan-ertugliflozine-sitagliptine-antidiabetique-oral
2019
false
true
false
false
France
French
SGLT2 Inhibitor
hypoglycemic agents
drug combinations
administration, oral
treatment outcome
sitagliptin and ertugliflozin
diabetes mellitus, type 2
drug interactions
adult
Sodium-Glucose transporter 2
Sitagliptin Phosphate
incretins
dipeptidyl-peptidase iv inhibitors
evaluation of the transparency committee
Sodium-Glucose Transporter 2 Inhibitors
guidelines for drug use
ertugliflozin
Bridged Bicyclo Compounds, Heterocyclic

---
https://www.has-sante.fr/portail/jcms/c_2913810/fr/steglatro
https://www.has-sante.fr/portail/jcms/c_2913810/fr/steglatro-ertugliflozine-antidiabetique-oral
2019
false
false
false
false
France
French
administration, oral
diabetes mellitus, type 2
treatment outcome
hypoglycemic agents
adult
ertugliflozin
SGLT2 Inhibitor
Sodium-Glucose transporter 2
evaluation of the transparency committee
Sodium-Glucose Transporter 2 Inhibitors
guidelines for drug use
ertugliflozin
Bridged Bicyclo Compounds, Heterocyclic

---
Steglujan - ertugliflozin / sitagliptin
https://www.ema.europa.eu/medicines/human/EPAR/Steglujan
2018
false
false
false
United Kingdom
French
English
syndication feed
summary of product characteristics
package leaflet
drug evaluation
SGLT2 Inhibitor
SGLT2 Inhibitor
hypoglycemic agents
hypoglycemic agents
drug combinations
administration, oral
europe
drug approval
treatment outcome
product surveillance, postmarketing
drug monitoring
sitagliptin and ertugliflozin
diabetes mellitus, type 2
drug interactions
pregnancy
breast feeding
adult
drug evaluation, preclinical
Sodium-Glucose transporter 2
Sitagliptin Phosphate
Sitagliptin Phosphate
incretins
incretins
dipeptidyl-peptidase iv inhibitors
dipeptidyl-peptidase iv inhibitors
Sodium-Glucose Transporter 2 Inhibitors
ertugliflozin
Bridged Bicyclo Compounds, Heterocyclic
ertugliflozin
ertugliflozin
Bridged Bicyclo Compounds, Heterocyclic
Bridged Bicyclo Compounds, Heterocyclic

---
Segluromet ertugliflozin / metformin hydrochloride
https://www.ema.europa.eu/medicines/human/EPAR/Segluromet
2018
false
false
false
United Kingdom
French
English
syndication feed
summary of product characteristics
package leaflet
drug evaluation
SGLT2 Inhibitor
SGLT2 Inhibitor
metformin
hypoglycemic agents
hypoglycemic agents
drug combinations
administration, oral
europe
drug approval
treatment outcome
product surveillance, postmarketing
drug monitoring
metformin and ertugliflozin
diabetes mellitus, type 2
drug interactions
pregnancy
breast feeding
adult
Metformin Hydrochloride
Metformin Hydrochloride
drug evaluation, preclinical
Sodium-Glucose transporter 2
Sodium-Glucose Transporter 2 Inhibitors
metformin
ertugliflozin
Bridged Bicyclo Compounds, Heterocyclic
ertugliflozin
ertugliflozin
Bridged Bicyclo Compounds, Heterocyclic
Bridged Bicyclo Compounds, Heterocyclic

---
Steglatro - ertugliflozin
https://www.ema.europa.eu/medicines/human/EPAR/Steglatro
2018
false
false
false
United Kingdom
French
English
syndication feed
summary of product characteristics
package leaflet
drug evaluation
administration, oral
diabetes mellitus, type 2
drug approval
europe
treatment outcome
hypoglycemic agents
hypoglycemic agents
product surveillance, postmarketing
drug monitoring
adult
ertugliflozin
SGLT2 Inhibitor
SGLT2 Inhibitor
Sodium-Glucose transporter 2
drug interactions
pregnancy
breast feeding
drug therapy, combination
Sodium-Glucose Transporter 2 Inhibitors
ertugliflozin
Bridged Bicyclo Compounds, Heterocyclic
ertugliflozin
ertugliflozin
Bridged Bicyclo Compounds, Heterocyclic
Bridged Bicyclo Compounds, Heterocyclic

---
https://hpr-rps.hres.ca/reg-content/sommaire-motif-decision-detailTwo.php?lang=fr&linkID=SBD00403
2018
false
false
false
Canada
French
drug information
administration, oral
hypoglycemic agents
hypoglycemic agents
diabetes mellitus, type 2
Sodium-Glucose transporter 2
drug approval
canada
treatment outcome
adult
drug therapy, combination
ertugliflozin
Sodium-Glucose Transporter 2 Inhibitors
ertugliflozin
ertugliflozin
Bridged Bicyclo Compounds, Heterocyclic
Bridged Bicyclo Compounds, Heterocyclic

---
Nous contacter.
02/05/2025


[Home] [Top]

© Rouen University Hospital. Any partial or total use of this material must mention the source.